For Year 2025-26, Vivo Bio Tech reports the following shareholding: Total Promoters at 35.16%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 64.84%. This breakdown provides a quick snapshot of ownership distribution for Vivo Bio Tech in 2025-26.